RS

Rakesh Solanki

Active Director Director DIN 10734134
DIN 10734134 First appointment Aug 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Rakesh Solanki

Data last updated:

Rakesh Solanki is a Director at Celleste Stemcell Therapy And Research-Cell Star Private Limited (since 2024).

DIN 10734134
Primary Designation Director
First Appointment 07 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Aug 20242024Active

Directorship timeline

Open interactive timeline →
Celleste Stemcell Therapy And Research-Cell Star Private Limited
Premium access

Shareholding and investment profile for Rakesh Solanki

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Solanki

Rakesh Solanki currently holds 1 directorship: Celleste Stemcell Therapy And Research-Cell Star Private Limited (Director, since 07 Aug 2024).

Rakesh Solanki was first appointed on 07 Aug 2024 as Director at Celleste Stemcell Therapy And Research-Cell Star Private Limited.

The current boards of Rakesh Solanki's companies include Divyangkumar Chimanlal Patel (Celleste Stemcell Therapy And Research-Cell Star Private Limited), Tejas Muraribhai Mehta (Celleste Stemcell Therapy And Research-Cell Star Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available